Alexandria, an S&P 500 company, is a best-in-class, mission-driven life science REIT making a positive and lasting impact on the world. With our founding in 1994, Alexandria pioneered the life science real estate niche. Alexandria is the preeminent and longest-tenured owner, operator, and developer of collaborative Megacampus ecosystems in AAA life science innovation cluster locations, including Greater Boston, the San Francisco Bay Area, San Diego, Seattle, Maryland, Research Triangle and New York City. Show more
Location: 26 North Euclid Avenue, Pasadena, CA, 91101-6104, United States | Website: https://www.are.com | Industry: REIT - Office | Sector: Real Estate
Market Cap
8.55B
52 Wk Range
$44.10 - $105.14
Previous Close
$49.17
Open
$49.18
Volume
2,007,139
Day Range
$48.92 - $49.60
Enterprise Value
21.93B
Cash
579.5M
Avg Qtr Burn
N/A
Insider Ownership
0.94%
Institutional Own.
98.02%
Qtr Updated
09/30/25
Drug Pipeline
Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
| Drug & Indication | Stage & Event | Catalyst Date |
|---|
